MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Mirum Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.24+2.10 (+2.62%)
Close on Oct 19, 2026
- Market cap
- $5.21B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Mirum Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 12, 2026 | Oct 13, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2026 | Sep 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | May 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2024 | Jun 17, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2024 | Jun 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 31, 2024 | May 31, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |